Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Pharmaceutical R&D: the road to positive returns

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Improving the return on small-molecule R&D.
Figure 2: Output of model.

Author information

Authors and Affiliations


Supplementary information

Supplementary information S1 (box)

Methodology to estimate the internal rate of return on R&D investments (PDF 296 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

David, E., Tramontin, T. & Zemmel, R. Pharmaceutical R&D: the road to positive returns. Nat Rev Drug Discov 8, 609–610 (2009).

Download citation

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing